Product NDC: | 55390-091 |
Proprietary Name: | Vinblastine Sulfate |
Non Proprietary Name: | Vinblastine Sulfate |
Active Ingredient(s): | 10 mg/10mL & nbsp; Vinblastine Sulfate |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55390-091 |
Labeler Name: | Bedford Laboratories |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA089395 |
Marketing Category: | ANDA |
Start Marketing Date: | 19960501 |
Package NDC: | 55390-091-10 |
Package Description: | 10 VIAL in 1 BOX (55390-091-10) > 10 mL in 1 VIAL |
NDC Code | 55390-091-10 |
Proprietary Name | Vinblastine Sulfate |
Package Description | 10 VIAL in 1 BOX (55390-091-10) > 10 mL in 1 VIAL |
Product NDC | 55390-091 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Vinblastine Sulfate |
Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 19960501 |
Marketing Category Name | ANDA |
Labeler Name | Bedford Laboratories |
Substance Name | VINBLASTINE SULFATE |
Strength Number | 10 |
Strength Unit | mg/10mL |
Pharmaceutical Classes | Vinca Alkaloid [EPC],Vinca Alkaloids [Chemical/Ingredient] |